Sign up to save your podcasts
Or
Share The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
906906 ratings
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Surveillance
1,200 Listeners
Bloomberg Intelligence
402 Listeners
Notes on the Week Ahead
189 Listeners
Insights Now
94 Listeners
Masters in Business
2,174 Listeners
Odd Lots
1,789 Listeners
Capital Allocators – Inside the Institutional Investment Industry
804 Listeners
Wall Street Breakfast
1,029 Listeners
UBS On-Air: Market Moves
181 Listeners
Making Sense
58 Listeners
Thoughts on the Market
1,267 Listeners
At Any Rate
80 Listeners
The Memo by Howard Marks
416 Listeners
Global Data Pod
24 Listeners
The Markets
70 Listeners